Thyrocare Technologies Ltd.
NSE: THYROCARE | BSE: 539871
₹579.00
₹-12.45
(-2.10%)
As on 31-Jul-2026IST
Market cap
₹9,218 Cr
Revenue (TTM)
₹876 Cr
P/E Ratio
52.3
P/B Ratio
14.6
Div. Yield
2.4 %
Quality Score
9/10
Growth Score
4/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹176 Cr
-
ROE
29 %
-
ROCE
38.3 %
-
Industry P/E
63.9
-
EV/EBITDA
30.7
-
Debt to Equity
0
-
Book Value
₹39.5
-
EPS
₹17.4
-
Face value
10
-
Shares outstanding
159,165,315
10 Years Aggregate
CFO
₹1,383.02 Cr
EBITDA
₹1,692.67 Cr
Net Profit
₹986.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 29.9 | 10.4 | 43.2 | 33.6 | 44.2 | 5.8 | 11.7 |
|
BSE Healthcare
| 17.0 | 3.6 | 13.8 | 10.8 | 22.3 | 14.2 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
| 45.0 | 39.8 | 4.0 | -44.1 | 18.1 | 69.2 | 1.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Thyrocare Tech
|
579.0 | 9,218.1 | 876.0 | 174.0 | 25.3 | 32.4 | 52.3 | 14.6 |
| 809.2 | 45,563.7 | 2,002.3 | 576.0 | 32.7 | 20.5 | 79.1 | 14.6 | |
| 1,905.2 | 31,976.9 | 2,890.8 | 546.3 | 23.0 | 23 | 59 | 12.2 | |
| 1,405.6 | 37,867.9 | 4,683.4 | 552.3 | 15.6 | 14.9 | 68.1 | 9.2 | |
| 331.5 | 10,821.7 | 1,557.8 | 187.8 | 16.1 | 12.8 | 55.8 | 7.0 | |
| 1,525.4 | 15,454.4 | 1,820.1 | 290.3 | 22.9 | 18.1 | 54.2 | 9.1 | |
| 608.9 | 2,717.6 | 418.8 | 79.7 | 23.6 | 18.5 | 34.1 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Best of both worlds: profits and dividends
4 min read•By Danish Khanna
2 min read•By Jugal Harpalani
Two unloved stocks to watch out for
4 min read•By Danish Khanna
About Thyrocare Tech
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services... segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Read more
-
Incorporated
2000
-
Chairman
Rahul Guha
-
Managing Director
Rahul Guha
-
Group
MNC
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Looking for more details about Thyrocare Technologies Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Thyrocare Tech
What is the current share price of Thyrocare Technologies Ltd Today?
The share price of Thyrocare Technologies Ltd is ₹579.00 (NSE) and ₹579.15 (BSE) as of 31-Jul-2026 IST. Thyrocare Technologies Ltd has given a return of 44.18% in the last 3 years.
What is the current PB & PE ratio of Thyrocare Technologies Ltd?
The P/E ratio of Thyrocare Technologies Ltd is 52.29 times as on 31-Jul-2026, a 18 discount to its peers’ median range of 63.90 times.
The P/B ratio of Thyrocare Technologies Ltd is 14.65 times as on 31-Jul-2026, a 53 premium to its peers’ median range of 9.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
34.07
|
9.62
|
|
2025
|
13.24
|
6.65
|
|
2024
|
44.13
|
6.00
|
|
2023
|
11.48
|
4.29
|
|
2022
|
7.75
|
7.82
|
What is the 52 Week High and Low of Thyrocare Technologies Ltd?
The 52-week high and low of Thyrocare Technologies Ltd are Rs 617.45 and Rs 342.55 as of 31-Jul-2026.
What is the market cap of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd has a market capitalisation of ₹ 9,218 Cr as on 31-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Thyrocare Technologies Ltd?
Before investing in Thyrocare Technologies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.